Posted in | News | Laser | Semiconductors | NanoOptics

Laser Light Source Extends Cymer's Leadership in the Dry ArF Market

Cymer, Inc., the market's leading developer of light sources used to create advanced semiconductor chips, has unveiled the XLR 500d-an argon fluoride (ArF) laser light source for 32 nanometer (nm) dry lithography. Expanding Cymer's market leadership with the adoption of its XLR technology, the XLR 500d offers advanced capabilities developed in the XLR 500i for advanced ArF immersion lithography. The light source's enhanced energy stability enables the use of fewer pulses per exposure, providing chipmakers with increased throughput and an overall reduction in operating costs.

“Over the past year, chipmaker and scanner customers have rapidly adopted Cymer's XLR platform for immersion lithography,” said Ed Brown, president and chief operating officer for Cymer. “With the introduction of the new XLR 500d, customers can now have access to all the advantages of our proven XLR platform for dry lithography as well as their advanced ArF immersion applications.”

As lithography is deployed into full 32nm production environments, Cymer's XLR 500d will bring the critical advantages of the XLR 500i into the dry ArF market. In addition to its proven Recirculating Ring technology and lower cost of consumables through longer life modules, customer benefits include improved energy and dose stability, better bandwidth stability leading to improved critical dimension (CD) uniformity on the wafer, and a longer interval between gas refills, made possible with Cymer's gas lifetime eXtension (GLX2TM) product – a stand-alone laser upgrade first introduced in November 2007 that extends the time between gas exchanges by a factor of 20.

Initial orders for the XLR 500d have been received and shipments are scheduled for the third and fourth quarter of 2008.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.